Skip to content

Clinical trials

Inflammatory Bowel Diseases trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Country / region: Brazil Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20113
20121
20131
20161
20213
20231
20245
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting7
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC4
Eli Lilly and Company2
Beneficência Portuguesa de São Paulo1
Genentech, Inc.1
InDex Pharmaceuticals1
Merck Sharp & Dohme LLC1
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1
Pfizer1
Sanofi1
Spyre Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases18
Colitis, Ulcerative8
Crohn Disease8
Colitis5
Gastrointestinal Diseases2
Gastroenteritis1
Insulin Resistance1
Obesity1
Overweight1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.